docetaxel anhydrous has been researched along with s-adenosylmethionine in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (s-adenosylmethionine) | Trials (s-adenosylmethionine) | Recent Studies (post-2010) (s-adenosylmethionine) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 5,987 | 198 | 1,872 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, J; Liu, G; Liu, J; Wu, J; Xin, P | 1 |
1 review(s) available for docetaxel anhydrous and s-adenosylmethionine
| Article | Year |
|---|---|
Biomedical applications of methionine-based systems.
Topics: Cell Proliferation; COVID-19; COVID-19 Drug Treatment; Docetaxel; Humans; Liver Diseases; Methionine; Nanoparticles; Neoplasms; S-Adenosylmethionine; SARS-CoV-2 | 2021 |